The role of IgE anti-basement membrane zone autoantibodies in bullous pemphigoid

Archives of Dermatology

Volumn 143, Issue 2, 2007, Pages 249-250

  Woodley, David T ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BASEMENT MEMBRANE ANTIBODY; COLLAGEN TYPE 17; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIGEN BINDING; AUTOIMMUNITY; BASEMENT MEMBRANE; BULLOUS PEMPHIGOID; EPITOPE MAPPING; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

AUTOANTIBODIES; BASEMENT MEMBRANE; HUMANS; IMMUNOGLOBULIN E; PEMPHIGOID, BULLOUS;

EID: 33847157514     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.2.249     Document Type: Note

References (14)

1. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of a complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 1988;82:1864-1870.
2. Diaz LA, Ratrie H III, Saunders WS, et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990;86:1088-1094.
3. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 1992;99:243-250.
4. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest. 1993;92:2480-2488.
5. Arbesman CE, Wypych JI, Reisman RE, Beutner EH. IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol. 1974;110:378-381.
6. Delaporte E, Dubost-Brama A, Ghohestani R, et al. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol. 1996;157:3642-3647.
7. Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol. 2000;143:349-355.
8. Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol. 2000;42:577-583.
9. Dimson OG, Giudice GJ, Fu C-L, Warren SJ, Janson MM, Fairley JA. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol. 2003;120:784-788.
10. Bowszyc-Dmochowska M, Silny W, Dmochowski M. Detection of IgG4 deposits using a single-step direct immunofluorescence on natrium chloride-separated skin and elevated levels of serum total IgE in active bullous pemphigoid. J Invest Dermatol. 2000;114:804a.
11. Fairley JA, Fu CL, Giudice GJ. Mapping the binding sites of BP180 IgE autoantibodies in bullous pemphigoid. J Invest Dermatol. 2005;125:467-472.
12. Dvorak AM, Mihm MC Jr, Osage JE, Kwan TH, Austen KF, Wintroub BU. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol. 1982;78:91-101.
13. Fairley JA, Burnett CT, Fu CL, Fleming MG, Giudice GJ. Injection of bullous pemphigoid (BP) IgE autoantibodies into human skin grafted to nu/nu mice replicates the urticarial stage of BP. J Invest Dermatol. 2005;124:A13.
14. Wintroub BU, Mihm MC Jr, Goetzl EJ, Soter NA, Austen KF. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med. 1978;298:417-421.